Open Access Open Access  Restricted Access Subscription Access
Cover Image


A. O. Ajayi, E. A. Ajayi, T. H. Raimi, J. O. Fadare, O. A. Solomon, A. O. Adeoti


About one third of cirrhotic patients with oesophageal varices (OV) develops an episode of oesophageal hemorrhage, and subsequently has high morbidity and mortality. Early detection and prevention of OV in these patients are crucial to minimizing complications. This study was carried out to determine the prevalence of OV among the cirrhotic patients at our institution. Fifty six patients with liver cirrhosis who had upper gastrointestinal endoscopy done were recruited into the study. The study was carried out at the Ekiti State University Teaching Hospital, Ado –Ekiti, between January 2010 and December 2011. Liver cirrhosis was diagnosed on the basis of liver biopsy, clinical and ultrasound findings. At the point of recruitment, a full medical history was taken. The severity of liver disease was assessed according to Child's classification. All the patients underwent upper gastrointestinal (GIT) endoscopy. The diagnosis of variceal bleeding was confirmed if an actively bleeding varix or a varix with adherent clot was seen. The following endoscopic features were recorded during the procedure: size, colour, and location of varices (oesophageal, fundal or portal gastropathy) and the presence of "red signs". Ethical approval for the study was obtained from hospital’s Ethics Committee and all the patients gave their individual signed consent. SPSS version 15.0 (SPSS, Inc., Chicago, Illinois, USA) was deployed for statistical analysis using the t-test for quantitative variables and χ2 test for qualitative variables. Differences were considered to be statistically significant if P value was less than 0.05. Fifty six cirrhotic patients comprising of 37 males and 19 females were recruited into the study. The Male: Female ratio was 1.9:1. The mean age for males was 51.6±10.2, while that of the females was 55.4±10.6. Oesophageal varices were found in 30 of the 56 patients giving an overall prevalence rate of 53.6%. All the varices were oesophageal in location; 73.3% (22/30) were males while 26.7% (8/30) were females. A large proportion (64.3%) of the patients were in Child’s grade A, while 28.5% were in Child’s Grade B and only 7.1% were in Child’s Grade C. Endoscopically, 13 of the varices were small (F1), 10 were medium sized (F2) while 7 were of large size (F3). The statistically significant risk factors for oesophageal varices found in this study were hepatitis B virus infection and tattoo marks. The prevalence of oesophageal varices in cirrhotic patients in this study was 53.6%. Upper gastrointestinal endoscopy is therefore recommended in the cirrhotic patients to ameliorate the risk of bleeding and the related high mortality.


Achinge, I.G., Malu, O.A., Okeke, E.N., Agaba, E.I., Misauno, M.A., 2011. Prevalence of oesophageal varices in newly diagnosed cirrhotic liver disease patients at The Jos University Teaching Hospital. Jos. Nig. Med. J., 52 (2), 128-132.

Aithal, G.P., Ryder, S.D., 2005. Liver disease. In Long RG, Scott BB, eds. Specialist Training in Gastroenterology and Hepatology. London. Elsev. Mosby., 184–202.

Arguedas, M.R., Heudebert, G.R., Eloubeidi, M.A., Abrams, G., Fallon, M.B., 2002. Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices. Am. J. Gastroenter ol., 97, 2441-2452.

Benedeto-Stojanov, D., Nagorni, A., Bjelakovic, G., Milanovic, J., Stojanov, D., 2006. Predictive factors of bleeding from oesophageal varices in patients with liver cirrhosis and portal hypertension. Series: Med. Biol., 13 (3), 164-167.

Bosch, J., Abraldes, J.G., Berzigotti, A., Garcia-Pagan, J.C., 2008. Portal hypertension and gastrointestinal bleeding. Semin Liver Dis., 28 (1), 3–25.

D’Amico, G., Pagliaro, L., Bosch, J., 1999. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis., 19, 475–505

de Franchis, R., Dell’Era, A., Primignani, M., 2008. Diagnosis and monitoring portal hypertension. Dig. Liver Dis., 40, 312–317.

de Franchis, R., 2010. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol., 53, 762–768.

Dib, N., Oberti, F., Cales, P., 2006. Current management of the complications of portal hypertension: variceal bleeding and ascites. Can. Med. Assn. J., 174, 1433–1443.

Garcia-Tsao, G., Sanyal, A.J., Grace, N.D., Carey, W., 2007. . Prevention and management of gastroesophageal varices and variceal heamorrhage in cirrhosis: Practice Guideline Committee of the American Association for the Study of the Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Hepatol., 46 (3), 922-938.

Grace, N.D., 1997. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. Am. J. Gastroenterol., 92, 1081-1091.

Graham, D.Y., Smith, J.L., 1981. The course of patients after variceal hemorrhage. Gastroenterology, 80:800–809.

Hegab AM, Luketic VA., 2001. Bleeding oesophageal varices. Postgrad. med. onl., 109, 75-89.

Lay, C.S., Tsai, Y.T., Teg, C.Y., et al., 1997. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatol., 25, 1346–1350.

Mahassadi, A.K., Bathaix, F.Y., Assi, C., Bangoura, A.D., et al., 2012. Usefulness of Noninvasive Predictors of Oesophageal Varices in Black African Cirrhotic Patients in Côte d'Ivoire (West Africa). Gastroenterol. Res. Pract., doi:10.1155/2012/216390.

Pagliaro, L., D’Amico, G., Pasta, L., Politi, F., Vizzini, G., Traina, M., et al., 1994. Portal hypertension in cirrhosis: Natural history. In: Bosch J, Groszmann RJ. Portal Hypertension. Pathophysiology and Treatment. Oxford. UK: Blackwell Sci., 72-92.

Roberts, L.R., Kamath, P.S., 1996. Pathophysiology and treatment of variceal hemorrhage. Mayo. Clin. Proc., 71, 973–983.

Samy, A.A., 2002. Oesophageal varices In: Waqar AQ, Francisco T, Bank S, Alex JM, Juian K eds. Gastroenterol. e-med. world med. library (CD-ROM).

Sarin, S.K., Ajay, K.J., Monica, J., Rajes, G., 2002. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am. J. Gastroenterol., 97, 1010-1015.

Sarin, S.K., Lamba, G.S., Kumar, M., Misra, A., Murthy, N.S., 1999. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N. Engl. J. Med., 340, 988–993.

Sarin, S.K., Lahoti, D., Saxena, S.P., Murthy, N.S., Makwana, U.K., 1992. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatol., 16, 1343- 1349.

Schepis, F., Camma, C., Niceforo, D., Magnano, A., Pallio, S., et al., 2001. Which patients with cirrhosis should undergo endoscopic screening for oseophageal varices detection. Hepatol., 33, 333-338.

Schepke, M., Kleber, G., Nurnberg, D., et al., 2004. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatol., 40, 65–72.

Sharma, S.K., Aggarwal, R., 2007. Prediction of large esophageal varices in patients with cirrhosis of the liver using clinical, laboratory and imaging parameters. J. Gastroenterol. Hepatol., 22, 1909–1915.

Sherlock, S., Dooley, J., 1997. Diseases of the liver and biliary system. Tenth edition. Blackwell Sci. Inc., USA.

Tripathi, D., Hayes, P.C., 2001. Review article: a drug therapy for the prevention of variceal haemorrhage. Aliment. Pharmacol. Ther., 15, 291–310.

Full Text: PDF


  • There are currently no refbacks.